Nc1ncnc2c1ncn2C1OC(COC2C(CO)OC(OC(C(=O)O)C(O)C(OP(=O)(O)O)C(O)C(=O)O)C(O)C2O)C(O)C1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?